Background: This paper was presented at the symposium which was organized by Instituto Danone Mexico in May 2001, and it provides an overview of the current scientific knowledge on fermented milks concerning the historical developments, manufacturing stages, classification of such products, and nutritional aspects. Particular attention has been paid to the human health benefits associated with the consumption of these products, the use of probiotic starter cultures and their industrial applications, and the significance of using a trained sensory panel for the evaluation of probiotic fermented milks made with different commercial blends of starter cultures. The paper also highlights the future research areas for the exploitation of starter microflora (Lactobacillus, Bifidobacterium and Enterococcus species) in fermented milk products. Conclusion: This review indicates that the complex metabolism of the starter cultures is well established; however, more information is still needed on specific microbial metabolites such as polymerization of milk sugars for the production of exopolysaccharides and the modification of the milk peptides and secretion of bacteriocins. More clinical studies are still required to establish the 'functional' health benefits of probiotic fermented milks to humans. Sponsorship: The visit to Mexico City was supported by Instituto Danone Mexico.
Introduction
Fermented milks are widely produced in many countries. This type of process is one of the oldest methods used to extend the shelf-life of milk, and has been practised by human beings for thousands of years. The exact origin(s) of the manufacture of fermented milks is difficult to establish, but it is safe to assume that it could date to more than 10 000 y ago as the way of life of humans changed from food gathering to food producing (Pederson, 1979) . This change also included the domestication of certain mammals such as the cow, sheep, goat, buffalo and camel; it is most likely that the transition occurred at different dates in different countries. However, archaeological evidence of certain civilizations (Sumerians, Babylonians, Pharos and Indians) suggests that they were well advanced in agriculture and in the production of fermented milks.
It is likely that the origin of these products was the Middle East and the Balkans, and the evolution of fermented milks through the ages could be attributed to the culinary skills of the inhabitants living in these regions. Today's fermented milk products are manufactured in many countries, and the stages of manufacture, which is still a complex process, combine the art of such ancient craft and science (microbiology and enzymology, physics and engineering, and chemistry and biochemistry) together.
This article summarizes the research findings on yoghurt and probiotic fermented milk products made from cow's milk over the past century.
Diversity of fermented milks
Fermented milks are manufactured throughout the world, and approximately 400 generic names are applied to traditional and industrialized products (Kurmann et al, 1992) , but in actual essence the list may only include few varieties. In the 1980s, Kurmann (1984) attempted, in part, the classification of fermented milks into a 'family tree' (see Figure 1 ; Bylund, 1995) , which was based primarily on the optimum growth requirements of the starter cultures (ie mesophilic and thermophilic microflora).
Nevertheless, taking into account the microorganisms that dominate the product, including their principle metabolites, Robinson and Tamime (1990) proposed a scheme for the classification of fermented milks as follows: lactic fermentations -(a) mesophilic type, eg cultured buttermilk, filmjölk, tätmjölk and långofil; (b) thermophilic type, eg yoghurt, Bulgarian butter-milk, zabadi, dahi; and (c) therapeutic or probiotic type, eg acidophilus milk, Yakult, ABT, Onka, Vifit); products within this group constitute by far the largest number known worldwide; yeast -lactic fermentations (kefir, koumiss, acidophilus yeast milk); and mould -lactic fermentations (villi). Tamime and Marshall (1997) have detailed the manufacturing stages of these types of fermentations. However, the so-called fermented milk 'drinks' and=or beverages including the carbonated products should be classified separately rather than being known as fermented milks; such an approach will minimize confusion among consumers. Nevertheless, some closely related products are manufactured from fermented milks by de-wheying, and some examples are labneh, skyr and ymer. The different methods available to manufacture concentrated fermented milks are as follows:
(a) cloth bag or Berge system; (b) mechanical or nozzle separators; (c) ultrafiltration (UF); and (d) product formulation (Tamime & Robinson, 1999) .
Patterns of consumption
Until the 1950s, production and=or consumption of yoghurt (ie natural type) was confined to communities in the Middle East, the Balkans, India, Eastern Europe, to ethnic groups living in different parts of the world, and to those who perceived that the product was beneficial to health. However, consumers' attitudes towards yoghurt have changed, possibly for the following reasons: (a) as refrigeration became widespread worldwide, the product became widely distributed and readily available on the market; (b) the introduction of a 'new' generation of yoghurts (eg addition of fruits and sugar) gave the product an entirely fresh image and it became an inexpensive snack or dessert; and (c) the advent of incorporation of probiotic bacteria into the product have enhanced the health benefits of fermented milks.
Consumption figures reflect the expanding markets in some selected countries between 1970 and 1999 (Table 1) . Until the early 1990s, fermented milks were classified as buttermilk, yoghurt and others according to the statistical data published by the International Dairy Federation, and such information provided consumption preferences of consumers in different countries; the current approach of Figure 1 The family tree of fermented milk types. Adapted from Kurmann (1984) .
Fermented milks -a review AY Tamime per capita consumption figures covers milk drinks and fermented milks including yoghurt. It could be argued, however, that this classification of these products may not provide a clear picture or patterns of consumption. Furthermore, in some countries, the consumption of buttermilk is not properly defined because: traditional=natural buttermilk is the by-product of butter making from ripened or cultured butter; cultured buttermilk is the fermentate of skimmed milk followed by the addition of butter flakes; and sweet buttermilk is not fermented; hence the data for buttermilk in such statistical tables have to be assessed in a cautious manner.
It is safe to conclude that fermented milk products that fall within the category of lactic fermentations (mesophilic type) are widely consumed in northern European countries, whilst the yeast -lactic fermented milks are popular in the Russian Federation, eastern European countries and Mongolia. Conversely, natural yoghurt is popular in countries between the Balkans and the Indian sub-continent, while the fruit flavoured and=or flavoured products are normally consumed in the rest of the world.
Little data is available on the world production figures of probiotic-fermented milks but during the last decade production has increased dramatically in some selected countries. For example, the French market of fermented milk containing Bifidobacterium spp. and Lactobacillus acidophilus increased from 1500 to > 91 000 tonnes between 1986 and 1990 (Renard, 1998) .
Definition and terminology of fermented milks including yoghurt
The existing legal standards or the provisional regulations of yoghurt in many countries classify the product on the basis of chemical composition or fat content (full, semiskimmed=medium or skimmed=low); the reviews by Robinson and Tamime (1976) , Pappas (1988) , Anonymous (1989 Anonymous ( , 1996 , FAO=WHO (1990) , and Tamime and Robinson (1999) are recommended for further reading.
The International Dairy Federation (IDF, 1992a,b) published general standards of identity of fermented milks that could be briefly defined as follows: 'Fermented milks are prepared from milk and=or milk products (eg any one or combinations of whole, partially or fully skimmed, concentrated or powdered milk, buttermilk powder, concentrated or powdered whey, milk protein (such as whey proteins, whey protein concentrates, soluble milk proteins, edible casein and caseinates), cream, butter or milkfat -all of which have been manufactured from raw materials that have been at least pasteurized) by the action of specific microorganisms, which results in a reduction of the pH and coagulation. It is of interest that in some countries the fortification of milk components with dried dairy ingredients during the manufacture, of yoghurt for example, is against the existing legal standards.
Other IDF specifications include the following aspects: (a) the starter cultures shall be viable, active and abundant ( 10 7 cfu=g) in the finished products at all times of sale for consumption; (b) these products may or may not be homogenized, must at least be pasteurized, contain certain permitted additives (optional), and have a shelf-life up to 30 days at 4 -7 C; (c) post-fermentation heat treatment shall not be allowed; and (d) de-wheying after fermentation is only permitted during the manufacture of concentrated fermented milk products such as labneh, ymer, skyr and stragisto. Furthermore, the identity of the starter cultures is also detailed and, in the case of yoghurt, Streptococcus thermophilus (formerly known as S. salivarius subsp. thermophilus) and Lactobacillus delbrueckii subsp. bulgaricus are normally used because of the associative growth that exists between these two microorganisms, whilst in some countries, Lactobacillus helveticus and Lactobacillus delbrueckii subsp. lactis (ie non-traditional organisms) are sometimes mixed with the starter culture. However, the name(s) of the so-called 'bio', therapeutic and=or probiotic fermented milks is not well established and should be addressed because consumers and=or some manufacturers in different countries consider all these products to be yoghurt (for more details refer to subsequent section).
The milk fermentates by mesophilic microorganism include the products that are grouped under lactic and yeast -lactic fermentations. The starter microorganisms of Robinson (1999) and IDF (2000) .
the former group belong to the genera of Lactococcus(Lac. lactis subsp. lactis, Lac. lactis subsp. lactis biovar diacetylactis and Lac. lactis subsp. cremoris) and Leuconostoc (Leu. mesenteroides subsp. cremoris and Leu. mesenteroides subsp. dextranicum), and they are normally used as mixed cultures. However, the microflora of the latter products is complex and not always constant; numerous species of lactic acid bacteria, yeasts and moulds have been found, for example, in the kefir grains. Tamime and Marshall (1997) have detailed the organisms that have been identified by many researchers in many countries. Traditionally, many products are made from 'natural' yoghurt in the Balkans and the Middle Eastern countries and these can be briefly described as follows: (a) dilution of the fermentate with water for the production of drinking yoghurt; (b) concentration of the yoghurt by de-wheying for the manufacture of strained yoghurt and yoghurt cheese; the latter product is formed into small balls and preserved in olive oil; (c) cultured butter and=or ghee can be made by churning full-fat yoghurt, and the aqueous phase is either utilized as drinking yoghurt or mixed with parboiled cracked wheat which is later sun-dried and milled into powder (such product is known as Kishk); and (d) surplus of yoghurt is preserved by drying or gently heating yoghurt for few hours over low and smokey fires (the end product is known as smoked yoghurt). Nevertheless, at present the classical approach to categorize yoghurt products is based on its physical characteristics as shown in Table 2 and, in particular, yoghurt is further sub-divided into different groupings based on the following aspects: legal and=or proposed standards classify the product, for example, on the fat content (full, medium or low); physical nature of the product (ie set or stirred; drinking yoghurt is normally considered as stirred-type of low viscosity); flavours of yoghurt are divided into plain=natural, fruit or flavoured; the latter two products are normally sweetened; probiotic, bio and=or therapeutic yoghurts contain non-traditional organisms beside Lb. delbrueckii subsp. bulgaricus and S. thermophilus (see Table 5 ); miscellaneous yoghurts include pre-fermentation processing (lactose hydrolysis or replacement of the animal fat with vegetable oil) or post-fermentation processing (vitamin fortification or heat treatment).
Technology of manufacture
Currently, the technological aspects of fermented milks are well established and extensively reviewed (Rasic & Kurmann, 1978; IDF, 1984 IDF, , 1986 IDF, , 1988 IDF, , 1992c Chandan, 1989; Tamime & Marshall, 1997; Tamime & Robinson, 1999) . The principal manufacturing stages and=or processes for all fermented milk products (set-or stirred-type) have many features in common, which can be briefly described as follows:
Preparation of the milk base The fat and the non-fat solid (SNF) contents of the milk are standardized and fortified to ensure compliance with existing legal standards. The fat level may range between < 0.5 and 5.0 g=100 g, whilst the SNF is increased to 14 g= 100 g (of which 5 g=100 g is protein). The fortification of the latter fraction(s) enhances the viscosity of the product, and the methods available include the addition of powders or concentration by evaporation or membrane filtration. It is recommended that recombination of powders is carried out at 40 C, and followed by filtration (to remove any undissolved or scorched particles) and de-aeration (to remove the air which is incorporated during recombination stage). The presence of air in the milk base does not provide the appropriate growth conditions of Lactobacillus acidophilus and bifidobacteria. It also increases heat-exchanger fouling, and affects the characteristics of the gel, especially the products fermented with mesophilic lactic starter cultures.
Homogenization
Advantageous physical -chemical changes caused by homogenization of the milk base occur during the manufacture of fermented milk, which may include: (a) a reduction in the diameter of fat to < 2 mm, these small globules being less inclined to coalesce into larger units and rise to the surface; (b) the milk becomes whiter in colour due to enhanced light reflectance and scattering; (c) an increase in viscosity of the product due to interaction and=or adsorption of the fat globules onto the casein micelles; and (d) a decrease in syneresis of the gel due to increase in its hydrophilicity and water-holding capacity as a result of the interaction(s) of the proteins.
A typical operating pressure used during the processing of the milk base ranges between 15 and 20 MPa at 60 -90 C, and the homogenizer (single-stage type) is placed upstream during the production of fermented milk. However, during the manufacture of buttermilk, homogenization of the milk base takes place on the downstream after the heat treatment stage and, after acidification, the gel is homogenized at 5 -10 MPa and 20 C; alternatively, two-stage homogenization of the milk base may be used (Tamime & Marshall, 1997; Tamime & Robinson, 1999; Tamime et al, 2001) . Heat treatment Different temperatures are used for the heat treatment of the milk base during the manufacture of fermented milk, and can vary depending on the time and temperature combinations. Some examples are: (a) 85 C for 30 min; (b) 90 -95 C for 5 min; and (c) 105 C for 10 s. Thermal treatment of the milk base induces numerous physical and chemical changes that are complex and multi-functional; the topic has been extensively studied (see the reviews by IDF, 1995; Tamime & Marshall, 1997; Tamime & Robinson 1999) , and in the context of fermented milks the effects of heat treatment are: destruction and=or elimination of pathogens and other microorganisms present in the milk base and, hence, the processed milk provides a good growth medium for the starter cultures; changes in the physical -chemical properties of the milk constituents, mainly the denaturation of the blactoglobulin, which forms a complex with k-casein; such interaction minimizes syneresis and improves the firmness of the gel; the protein=fat interaction in milk should not be overlooked; production of components that are stimulatory to the starter cultures.
Starter culture
The heated milk base is cooled to the desired incubation temperature of the product; some examples are: (a) yoghurt at 40 -45 C for up to 3 h, at 30 C for 18 h or 5 h when using direct-to-vat inoculation (DVI) starter culture; (b) probiotic products at 37 C for a few hours or up to 5 -7 days depending on the organism(s) used; (c) buttermilk at 20 -30 C for up to 10 -20 h; and (d) kefir at 22 C for 16 -24 h depending on the type of kefir grains used (Tamime & Marshall, 1977; Wszolek et al, 2001) .
Gel formation in milk is mediated by acid coagulation due to the activity of the starter cultures and their enzymes to hydrolyse the lactose and to a lesser degree the proteins. The mechanisms involved of casein dissociation and aggregation during acid-induced gelation of milk are pH-, ion concentration-and temperature-dependant, and these aspects of gelation are similar for set-or stirred-type fermented milks; in the former type, the milk is incubated in the retail container, whilst for the stirred product the milk is incubated in large fermentation tanks.
Cooling and miscellaneous handling
Cooling is only method used to control the metabolic activity of the starter cultures and their enzymes in order to retain an abundant count of these organisms in fermented milks. The primary objective is to cool the product to 5 C, and the process of cooling commences at 4.6 pH, which is carried out using a one-or two-phase cooling. The latter method is widely applied during the manufacture of fruit-flavoured fermented milk products; the first stage of cooling, for example for yoghurt, reduces the temperature from 45 to 20 -25 C prior to the addition of fruit and packaging, and the second phase of cooling takes place in the cold store (chill tunnel is optional), where the product is cooled to < 10 C (Tamime & Robinson, 1999; Tamime et al, 2001 ).
Historical background on probiotic fermented milks
The gross chemical composition of fermented milks provides a useful indication of the potential nutritional value of these products. The main components are protein, fat, carbohydrate, minerals and vitamins. However, the bioactive peptides (eg casomorphins, a-and b-lactorphin, immunopeptides, lactoferricin or phosphopeptides), which are claimed to be health-enhancing components, should not be overlooked (Meisel & Bockelmann, 1999) . The beneficial health properties of these products and their use in the treatment of body ailments dates back to few thousands years ago; they have been also mentioned in Biblical scriptures, and some ancient scientists have prescribed them as medicine for curing metabolic disorders of the stomach and the intestine (Oberman & Libudzisz, 1998) . However, the health aspects of fermented milks including yoghurt became apparent in the late 1800s and the early part of the 1900s; in part, this could be attributed to the scientific observations and=or explanations by Tissier and Moro (Rasic & Kurmann, 1983) and Metchnikoff (1910) . Tisser had isolated Bacillus bifidus communis (currently known as Bifidobacterium bifidum) and this microorganism was predominant in the faeces of breast-fed infants, whilst Moro around the same period isolated Bacillus acidophilus (currently known as Lactobacillus acidophilus) from the stools of breast-fed infants. Metchnikoff (1910) put forward the beneficial effects of lactic acid bacteria (Bulgarian bacillus, which was later designated Lactobacillus bulgaricus and currently known as Lb. delbrueckii subsp. bulgaricus), that were present in 'yahourth', and postulated the 'longevity-without-aging' of the Caucasians with high consumption of such product. As a consequence, the views and=or observations of Tisser, Moro and Metchnikoff caused a considerable flurry of interest among scientists and=or doctors regarding the beneficial role of certain microorganisms (eg Bifidobacterium spp. and the yoghurt starter cultures) that can colonize and possibly displace toxin-producing organisms that are present in the intestinal tract of humans. These aspects have initiated scientific studies on the human health benefits associated with lactic acid bacteria in fermented milks, and it was not until the early part of the last century that Lb. acidophilus was identified as being able to colonize and proliferate in humans rather than Lb. delbrueckii subsp. bulgaricus and S. thermophilus (Rettger & Cheplin, 1921; Rettger et al, 1935) . Research studies in this field have been enormous over the past years, and the knowledge acquired in terms of human health benefits of fermented milks has helped, in part, to increase the consumption of these products in many 
Probiotic microorganisms
The current definition of probiotics, as agreed by European scientists, is 'a live microbial feed supplement that is beneficial to health' (Salminen et al, 1998a) . However, the microflora of the human intestinal tract in both infants and adults is highly complex and many bacterial species have been identified; the topic has been extensively researched, and the following selected reviews provide relevant information with specific emphasis on probiotic microorganisms and their health applications to humans (Robinson, 1991; Fuller, 1992 Fuller, , 1997 Sanders, 1994; Salminen et al, 1996a Salminen et al, , 1998b Marshall & Tamime, 1997a; Holzapfel et al, 1998; Salminen & von Wright, 1998; Dunne et al, 1999; Hirayama & Rafter, 1999; Lee et al, 1999; Tannock, 1999; Fuller & Perdigon, 2000; Salminen, 2001) . Periodically, Danone Vitapole Recherché publishes monographs (Capron et al, 2000; Malagelada et al, 1999; Denariaz et al, 1999; Gibson et al, 2000; Hartley et al, 2001) and World Newsletter (23 issues have been published) updating the health aspects associated with fermented milks. As mentioned earlier, lactic acid bacteria, yeast, moulds or combinations of these are widely used in the production of fermented milks and cheeses. The characteristics of these microorganisms have been recently reviewed by Tamime (2002) , and only the relevance of probiotic microflora in fermented milks will be discussed. It is evident that these bacterial species have to withstand the acidic and bile salts conditions in the gastro-intestinal tract of humans when compared with 'traditional' dairy starter cultures, and reach and=or colonize the large intestine. Researchers in different countries have identified many probiotic microorganisms, and Table 3 illustrates some examples.
The recent taxonomy and physiology of probiotic lactobacilli species have been reported by Klein et al (1998) , and these species belonged to: (a) Lb. acidophilus group; (b) Lb. casei group; and (c) Lb. reuteri=Lb. fermentum group; most Lb. acidophilus strains used in the manufacture of probiotic fermented milks have been identified as Lb. johnsonii or Lb. gasseri; both species are members of the Lb. acidophilus group. Hence, the issue of health-promoting properties of such products is questionable, and it cannot be assumed that all strains of Lb. acidophilus have or possess the desirable properties of probiotic microorganisms (Salminen et al, 1996b; Hamilton-Miller & Gibson, 1999; Ouwehand et al, 1999) ; furthermore, not all the commercial probiotic fermented milk products disclose the strain or species used or the actual numbers (Hamilton-Miller, 1999; Sanders & Huis in't Veld, 1999) . In some instances, researchers have referred to Lb. rhamnosus GG as Lb. acidophilus, Lb. casei subsp. casei or Lb. paracasei subsp. paracasei.
Until the mid 1980s, the genus Bifidobacterium was classified as Lactobacillus spp. and currently 30 different species of bifidobacteria have been identified. The six organisms that have been used in dairy products are shown in Table 3 but, according to Klein et al (1998) , most of the strains used in Adopted from Tamime and Robinson (1999) .
Fermented milks -a review AY Tamime probiotic fermented milks are B. animalis, although they are declared on some labels as B. longum. B. animalis was renamed B. lactis in the late 1990s (Meile et al, 1997) , and now it is re-classified as B. animalis (Cai et al, 2000) . In my view, the term 'bifidus' should not be used because it is old terminology (Lactobacillus bifidus), and can cause some confusion to the reader. The 16S rRNA sequencing within the genus Entrococcus has revealed the presence of three species groups: E. faecium and E. durans are found in the first group, whilst E. faecalis forms an individual line of descent. However, the pathogenicity of these organisms should not be overlooked when they are used in probiotic fermented milk products.
Limited data are available on the use of the probiotic yeast (Saccharomyces boullardii) in fermented milks (LourensHattingh & Viljoen, 2001a) , and the most likely application is Kefir and Koumiss making. Other non-lactic acid bacteria that have been used in probiotic products around the world include Bacillus cereus, Escherichia coli and Clostridum butyricum (Shortt, 1999) .
Therapeutic properties of bio-fermented milks
It is well established that the probiotic microorganisms shown in Table 3 have therapeutic properties, and when they are added with 'traditional' starter cultures during the manufacture of fermented milks (see later), such products have certain health-promoting activities in humans; Table 4 attempts to highlight the possible advantages. However, upto-date reports on some of the clinical=nutritional studies on humans using probiotic fermented milks and their successful applications in the treatment of certain human diseases, include the following: (a) adherence of probiotic microorganisms to human intestinal cells; (b) decreasing faecal mutagenecity; (c) improvement of constipation; (d) production of bacteriocins; (e) effects on superficial bladder cancer; and (f) effect on the human salivary microflora (MattilaSandholm & Salminen, 1998; Salminen et al, 1998b; MattilaSandholm et al, 1999a,b; Ouwehand et al, 1999; Petti et al, 2001) . Some selected studies on nutritional aspects relating to humans have been reported by Oberhelman et al (1999) , Alander et al (1999) , Lee et al (1999) , Kar (1999) , Ashar and Currently it is reclassified as B. animalis (Cai et al, 2000) . Yogurt starter cultures have been found in the product rather than bifidobacteria (Sanders & Huis in't Veld, 1999 ).
e Lb. casei þ Lb. delbrueckii subsp. bulgaricus were the only organisms identified in the product (Sanders & Huis in't Veld, 1999) . f Lb. rhamnosus was the only organism present in the product (Sanders & Huis in't Veld, 1999) g Lb. johnsonii þ S. thermophilus were found in the product (Sanders & Huis in't Veld, 1999) . Data compiled from Tamime et al (1995) , Tamime (1998) , Sanders and Huis in't Veld (1999) and Lee et al (1999) . Another aspect, which has links with gut health, involves prebiotics; they are defined as 'non-digestible food ingredients' that beneficially affect the host by selectively stimulating the growth and=or activity of one or limited number of bacteria in the colon, that have the potential to improve the host health' (Gibson & Roberfroid, 1995) . Most potential prebiotic food ingredients are carbohydrate-based components such as oligosaccharides (Hartemink, 1999; Gibson & Angus, 2000) . However, a mixture of probiotic microorganisms and prebiotic food ingredient is known as synbiotic.
Commercial probiotic fermented milk products
Some of the critical aspects that can affect the quality of fermented milks are: (a) good make which is attributed to fast acid development using traditional starter cultures; acid development of probiotic starter cultures is poor in comparison with Lb. delbrueckii subsp. bulgaricus and S. thermophilus; (b) stable product after manufacture where few undesirable microorganisms can withstand the rapid acid development or initiate growth at pH 4.6; and (c) the lactic and sour flavour is the characteristic flavour acidity of majority of traditional types of mesophilic and thermophilic fermented milks, and the action of acid on the milk proteins (mainly the casein) is important in texture formation of the product. However, the heterofermentation by the bifidobacteria results in lactic and acetic acid production; the latter acid has a harshness which is undesirable for milk products (Marshall & Tamime, 1997b) .
As a consequence, the majority of commercially available probiotic fermented milks in different markets of the world (ca 80 -100) are made with a mixture of non-traditional and traditional starter cultures, and detailed examples have been reported by Hoier (1992) , Tamime et al (1995) , Tamime & Marshall (1997) , Holzapfel et al (1997) (1995) , Maisnier-Patin et al (1996) , Dave and Shah (1997) , Marshall and Tamime (1997a) , McAuliffe et al (1998) , Papathanasopoulos et al (1998) , Anderssen et al (1998) , Kawai et al (1998) , Suma et al (1998 ), van Reenen et al (1998 , Yildirim and Johnson (1998), Farias et al (1999) , Remiger et al (1999) , Fujiwara et al (1999) , Zhu et al (2000) , Gänzle et al (2000) .
Fermented milks -a review AY Tamime and Tamime (1998) (see Table 5 ); hence, probiotic microorganisms are used as therapeutic adjuncts in fermented milk products (see also the review by Lourens-Hattingh & Viljoen, 2001b) .
Exopolysaccharides (EPS) production
Microbial EPS material is synthesized by certain strains of lactic acid bacteria, and it can enhance the rheological properties (ie minimize syneresis, improve the texture and modify the structure) and sensory perception (ie firmness and creaminess) of fermented milks and other dairy products. The topic has been extensively reviewed (IDF, 1998; Cerning & Marshall, 1999) , and illustrations of the microstructure of both mesophilic and thermophilic fermented milks have been reported by Tamime and Marshall (1997) and Tamime and Robinson (1999) . Quantitative and qualitative properties of EPS material are influenced by the following aspects: (a) microbial strain; (b) composition of the growth medium and=or growth factors; and (c) processing conditions that include the growth temperature and time of fermentation. In 2001, the scientific papers presented at the first Symposium on EPS from Lactic Acid Bacteria provided an up-to-date review of this field, including their applications in the dairy industry and the structures of EPS (Monsan et al, 2001; Boels et al, 2001; Jolly & Stingele, 2001; Degeest et al, 2001; Duboc & Mollet, 2001; Marshall et al, 2001) . However, some of these EPS materials contain gluco-and=or fructo-oligosaccharides and may generate short-chain fatty acids upon hydrolysis in the intestinal tract by the colonic microflora, and may have potential health (eg an anti-tumor effect, cholesterol-lowering effects or immune-modulators effects) and nutritional benefits as a prebiotic to the intestinal microflora.
Bacteriocin production
Bacteriocins are antibacterial substances produced by certain groups of microorganisms including probiotic and lactic acid bacteria; they are also known as 'colicin-like' inhibitory substances. Incidentally, bacteriocins are usually segregated from antibiotic compounds, and such naturally produced metabolites inhibit the growth of undesirable microorganisms in food and dairy products. In the case of lactic acid bacteria, the bacteriocins produced could be used to replace added chemical preservatives and, hence, the shelf-life of the product could be extended by natural means; however, these inhibitors can also affect certain strains of starter cultures.
At present more than 70 different types of bacteriocins have been identified as produced by lactic acid bacteria. Table 6 summarizes some selected characteristics (for further information refer to de Vuyst & Vandamme, 1994; Holzapfel et al, 1995; Desmazeaud, 1994; Nes et al, 1996; Richard, 1996; Marshall & Tamime, 1997a) .
Partial characterization of the quality of probiotic fermented milks
Many diversified probiotic dairy products are currently available to consumers in many markets, and some examples are: pasteurized liquid milk, cheeses, ice-cream, milk powder feed for infants and fermented milks (Tamime & Marshall, 1997) . However, fermented milk products are the most popular vehicle used in the industry for the implantation of the probiotic microflora in humans. In the mid 1990s, a collaborative research programme was established between the Scottish Agricultural College (SAC) and the Hannah Research Institute (HRI) to evaluate the quality (chemical composition, microbiological analysis, rheological properties and sensory perception) of different types of newly developed The starter cultures produces exopolysaccharide (EPS) material f This is a yoghurt starter culture, which is used as a control.
The symbol (P) denotes the presence of the microorganism in the starter culture.
Fermented milks -a review AY Tamime fermented milk products (eg vegetable oil yoghurt, kishk, yoghurt made with fat substitutes, kefir and probiotic fermented milks). In this paper, some aspects of the quality of probiotics fermented milks will be reported, and for further details refer to La Torre (1997), Hartley et al (2001) and La Torre et al (2002) . In the first instance, single strains of Bifidobacterium spp. (B. adolescentis NCFB 2230, B. bifidum NCFB 2715, B. breve NCFB 2258, B. infantis NCFB 2205 and B. longum NCFB 2259, were obtained from National Collection of Food Bacteria; B. longum BB 46 and B. bifidum BB11 -B. longum BBL and BL and B. infantis 410 -B. longum 2 and 913 were obtained from Chr. Hansen, Rhodia and Visby, respectively) were used to manufacture fermented milks. The quality of the products made with the NCFB strains did not satisfy the minimum requirements, the pH values were borderline (eg between 4.8 and 5.4), excessive whey separation was evident, the coagulum was extremely week and, in some cases, the odour and taste were unpleasant. However, slight improvement in the quality of the product was evident, especially when the milk bases were fortified with Raftaline 1 or Jerusalem artichoke, but the overall pHs ranged between 4.79 and 5.91 after 24 h of incubation (with the exception of strains of B. longum BBL and 2; pH 4.6). As the results were not satisfactory, it was decided that commercial mixed blends of starter cultures containing lactic acid bacteria and different Bifidobacterium species would be used (see Table 7 ).
The quality of the fermented milks was superior to those made with single strains of bifidobacteria, and the results could be summarized as follows:
Acidification of the milk base (total solids, protein and fat were 14.5, 5.5 and 1.5 g=100 g, respectively) ranged between 6 and 10 h or 13 and 22 h for pH 4.4. Organic acid profiling indicated that the starter cultures produced appreciable quantities of lactic acid, and only two cultures (AB and AC=BL) produced the high levels of acetic acid (3229 and 2794 mg=g, respectively; figures are averages of three trials and of fresh and stored products). The viable cell counts in fresh and stored products for bifidobacteria varied (eg two cultures (AB and AC=BL) showed an increase, three cultures (DVB-100, ABT 3 and MSKB 2) remained constant, and two cultures (ABT 1 and MSK 2) exhibited a slight decline); Lb. acidophilus increased during production but, in some products (DVB-100, MSK 2, ABT 1 and 3 and MSKB 2), the counts were Table 7 . After La Torre (1997) . Figure 3 Interpretation of sensory results for fermented milk products. After La Torre (1997) .
Fermented milks -a review AY Tamime decreased after storage; S. thermophilus counts of all starter cultures showed a remarkable increase during production and survival during storage. Syneresis values of fermented milks ranged between 2.5 and 3.0 ml for fresh products and decreased to 1.5 -2.5 ml after 20 days' storage at 5 C; the rate of decrease was dependent on the starter culture used. The firmness measurements of all fermented milks increased over time, and the rate was independent of the starter culture used; after the storage period, the firmness values ranged between 1.8 and 2.5 N for the EPS cultures MSKB 2 and ABT 1, respectively. Sensory analysis indicated the following: (a) 'acid', 'creamy' and=or 'other' characters (for the odour, flavour and after-taste attributes) were significant (P < 0.001); (b) the flavour character 'other' was identified to the presence of a high level of acetic acid produced by two starter cultures (AB and AC=BL); (c) analysis of variance accounted for over 95% of the first three factors, explaining 52.0, 30.7 and 12.9%, respectively; and (d) sensory space maps were constructed that grouped the starter cultures into different clusters based on the identified significant attributes (see Figure 2) . Factors 1 and 2 clearly separated the cultures AB, AC=BL and MSK 2 from the others, and cultures MY 087 and MSKB 2 were slightly separated from the grouping of ABT 1, ABT 3 and DVB-100 cultures. Separation on factor 1 was mainly associated with differences in acid character, whilst factor 2 resolved the fermented milk products in terms of the contrast between 'creamy=sweet' odour and 'other' (ie vinegar) flavour (see Figure 3) . It is possible to conclude that the level of metabolites (mainly acetic acid) produced by the bacterial strain(s) can influence the organoleptic assessment.
Conclusion
It is evident that fermented milks can be successfully produced using different blends of lactic acid bacteria and probiotic microorganisms. Over the past century, voluminous scientific knowledge has been well established regarding the technological aspects of fermented milks, including the physiology of starter cultures and related probiotic microflora. However, over the coming years the possible research areas may include the following aspects: appropriate international definition(s) of yoghurt and other fermented milks including probiotic products; more properly designed clinical studies to establish the proper health benefits to humans; in vitro results cannot be found always in vivo, and observations reported in animals cannot be translated directly to humans; there are problems in generalizing the results given the large number of types of microorganisms used and, in some instances, the count of probiotic microorganisms in clinical studies is not reported; clinical studies should be conducted on humans of different races in different countries to properly substantiate the health benefits to humans in general; how the starter culture polymerizes lactose in milk to produce exopolysaccharide material; what induces the microorganisms to cyclize the peptide(s) to secrete bacteriocins and what their mechanism(s) for controlling pathogens in the gut is (are); the pathogenicity of certain cultures requires further clearance.
